CN101088523A - 黄芩天然活性成分的固体脂质纳米粒及其制备方法和制剂 - Google Patents
黄芩天然活性成分的固体脂质纳米粒及其制备方法和制剂 Download PDFInfo
- Publication number
- CN101088523A CN101088523A CNA2006100874792A CN200610087479A CN101088523A CN 101088523 A CN101088523 A CN 101088523A CN A2006100874792 A CNA2006100874792 A CN A2006100874792A CN 200610087479 A CN200610087479 A CN 200610087479A CN 101088523 A CN101088523 A CN 101088523A
- Authority
- CN
- China
- Prior art keywords
- solid lipid
- preparation
- lipid nanoparticle
- radix scutellariae
- medicine carrying
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000002632 lipids Chemical class 0.000 title claims abstract description 23
- 239000002245 particle Substances 0.000 title claims abstract description 10
- 239000007787 solid Substances 0.000 title abstract description 7
- 241000050051 Chelone glabra Species 0.000 title abstract 7
- 238000000034 method Methods 0.000 title description 8
- 230000008569 process Effects 0.000 title description 2
- 238000002360 preparation method Methods 0.000 claims abstract description 52
- IPQKDIRUZHOIOM-UHFFFAOYSA-N Oroxin A Natural products OC1C(O)C(O)C(CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IPQKDIRUZHOIOM-UHFFFAOYSA-N 0.000 claims abstract description 31
- IKIIZLYTISPENI-ZFORQUDYSA-N baicalin Chemical compound O1[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IKIIZLYTISPENI-ZFORQUDYSA-N 0.000 claims abstract description 31
- 229960003321 baicalin Drugs 0.000 claims abstract description 31
- AQHDANHUMGXSJZ-UHFFFAOYSA-N baicalin Natural products OC1C(O)C(C(O)CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 AQHDANHUMGXSJZ-UHFFFAOYSA-N 0.000 claims abstract description 31
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 24
- 238000002347 injection Methods 0.000 claims abstract description 23
- 239000007924 injection Substances 0.000 claims abstract description 23
- 239000000243 solution Substances 0.000 claims abstract description 7
- HIMJIPRMECETLJ-UHFFFAOYSA-N Wogonin Natural products COc1cc(O)c(O)c2C(=O)C=C(Oc12)c3ccccc3 HIMJIPRMECETLJ-UHFFFAOYSA-N 0.000 claims abstract description 6
- XLTFNNCXVBYBSX-UHFFFAOYSA-N wogonin Chemical compound COC1=C(O)C=C(O)C(C(C=2)=O)=C1OC=2C1=CC=CC=C1 XLTFNNCXVBYBSX-UHFFFAOYSA-N 0.000 claims abstract description 6
- 239000002047 solid lipid nanoparticle Substances 0.000 claims description 42
- 239000003814 drug Substances 0.000 claims description 39
- 239000000725 suspension Substances 0.000 claims description 19
- 241000207929 Scutellaria Species 0.000 claims description 16
- 239000011159 matrix material Substances 0.000 claims description 15
- 239000000843 powder Substances 0.000 claims description 13
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 12
- 210000003022 colostrum Anatomy 0.000 claims description 11
- 235000021277 colostrum Nutrition 0.000 claims description 11
- 238000001914 filtration Methods 0.000 claims description 11
- 230000001804 emulsifying effect Effects 0.000 claims description 9
- 239000000839 emulsion Substances 0.000 claims description 9
- 125000005456 glyceride group Chemical group 0.000 claims description 9
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical class C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims description 8
- 239000003995 emulsifying agent Substances 0.000 claims description 8
- 230000005496 eutectics Effects 0.000 claims description 8
- 239000004615 ingredient Substances 0.000 claims description 8
- 239000007788 liquid Substances 0.000 claims description 8
- 239000008176 lyophilized powder Substances 0.000 claims description 8
- 239000002105 nanoparticle Substances 0.000 claims description 8
- 239000001993 wax Substances 0.000 claims description 8
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 claims description 7
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 claims description 7
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 claims description 7
- 239000005642 Oleic acid Substances 0.000 claims description 7
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 claims description 7
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 claims description 7
- 239000000203 mixture Substances 0.000 claims description 7
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 claims description 7
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 claims description 7
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 6
- 239000007957 coemulsifier Substances 0.000 claims description 6
- 239000004094 surface-active agent Substances 0.000 claims description 6
- 239000000084 colloidal system Substances 0.000 claims description 5
- 238000009472 formulation Methods 0.000 claims description 5
- 229920001223 polyethylene glycol Polymers 0.000 claims description 5
- 239000007921 spray Substances 0.000 claims description 5
- 239000003381 stabilizer Substances 0.000 claims description 5
- 230000003637 steroidlike Effects 0.000 claims description 5
- 238000003756 stirring Methods 0.000 claims description 5
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 claims description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 4
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 4
- 208000035126 Facies Diseases 0.000 claims description 4
- 229930195725 Mannitol Natural products 0.000 claims description 4
- 240000004534 Scutellaria baicalensis Species 0.000 claims description 4
- 235000017089 Scutellaria baicalensis Nutrition 0.000 claims description 4
- 235000012000 cholesterol Nutrition 0.000 claims description 4
- 239000000594 mannitol Substances 0.000 claims description 4
- 235000010355 mannitol Nutrition 0.000 claims description 4
- 239000000463 material Substances 0.000 claims description 4
- -1 polyoxy Polymers 0.000 claims description 4
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims description 3
- 241000283153 Cetacea Species 0.000 claims description 3
- 239000002253 acid Substances 0.000 claims description 3
- 239000000443 aerosol Substances 0.000 claims description 3
- 239000003963 antioxidant agent Substances 0.000 claims description 3
- 230000003078 antioxidant effect Effects 0.000 claims description 3
- 239000008346 aqueous phase Substances 0.000 claims description 3
- 235000011089 carbon dioxide Nutrition 0.000 claims description 3
- 239000002738 chelating agent Substances 0.000 claims description 3
- 239000003795 chemical substances by application Substances 0.000 claims description 3
- 150000002148 esters Chemical class 0.000 claims description 3
- 238000000605 extraction Methods 0.000 claims description 3
- 230000004927 fusion Effects 0.000 claims description 3
- 239000004200 microcrystalline wax Substances 0.000 claims description 3
- 235000019808 microcrystalline wax Nutrition 0.000 claims description 3
- 210000002200 mouth mucosa Anatomy 0.000 claims description 3
- 210000002850 nasal mucosa Anatomy 0.000 claims description 3
- 230000002685 pulmonary effect Effects 0.000 claims description 3
- 210000001533 respiratory mucosa Anatomy 0.000 claims description 3
- 235000021355 Stearic acid Nutrition 0.000 claims description 2
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 2
- 150000007513 acids Chemical class 0.000 claims description 2
- 150000001336 alkenes Chemical class 0.000 claims description 2
- 239000003242 anti bacterial agent Substances 0.000 claims description 2
- 230000000844 anti-bacterial effect Effects 0.000 claims description 2
- 239000000306 component Substances 0.000 claims description 2
- 238000007334 copolymerization reaction Methods 0.000 claims description 2
- 239000006185 dispersion Substances 0.000 claims description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid ester group Chemical class C(CCCCCCCCCCC)(=O)O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 claims description 2
- 238000004945 emulsification Methods 0.000 claims description 2
- 229940075507 glyceryl monostearate Drugs 0.000 claims description 2
- 239000002563 ionic surfactant Substances 0.000 claims description 2
- 150000004668 long chain fatty acids Chemical class 0.000 claims description 2
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 2
- 238000002156 mixing Methods 0.000 claims description 2
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 claims description 2
- 229910052757 nitrogen Inorganic materials 0.000 claims description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 claims description 2
- 239000003960 organic solvent Substances 0.000 claims description 2
- 235000010603 pastilles Nutrition 0.000 claims description 2
- 238000000926 separation method Methods 0.000 claims description 2
- 239000008117 stearic acid Substances 0.000 claims description 2
- 239000000811 xylitol Substances 0.000 claims description 2
- 235000010447 xylitol Nutrition 0.000 claims description 2
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 2
- 229960002675 xylitol Drugs 0.000 claims description 2
- 239000000654 additive Substances 0.000 claims 2
- OBRNDARFFFHCGE-QDSVTUBZSA-N arformoterol fumarate Chemical compound OC(=O)\C=C\C(O)=O.C1=CC(OC)=CC=C1C[C@@H](C)NC[C@H](O)C1=CC=C(O)C(NC=O)=C1.C1=CC(OC)=CC=C1C[C@@H](C)NC[C@H](O)C1=CC=C(O)C(NC=O)=C1 OBRNDARFFFHCGE-QDSVTUBZSA-N 0.000 claims 2
- 238000012377 drug delivery Methods 0.000 claims 2
- 239000006187 pill Substances 0.000 claims 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims 1
- 230000015572 biosynthetic process Effects 0.000 claims 1
- 239000002775 capsule Substances 0.000 claims 1
- 229960000193 formoterol fumarate Drugs 0.000 claims 1
- 239000000499 gel Substances 0.000 claims 1
- 239000008187 granular material Substances 0.000 claims 1
- 239000012528 membrane Substances 0.000 claims 1
- 210000004379 membrane Anatomy 0.000 claims 1
- 239000002674 ointment Substances 0.000 claims 1
- 239000003380 propellant Substances 0.000 claims 1
- 239000007901 soft capsule Substances 0.000 claims 1
- 238000005516 engineering process Methods 0.000 abstract description 6
- 238000002144 chemical decomposition reaction Methods 0.000 abstract description 2
- 210000004400 mucous membrane Anatomy 0.000 abstract 1
- 229940090044 injection Drugs 0.000 description 19
- 229940079593 drug Drugs 0.000 description 9
- 239000003921 oil Substances 0.000 description 7
- 235000019198 oils Nutrition 0.000 description 7
- 239000012071 phase Substances 0.000 description 7
- 235000013336 milk Nutrition 0.000 description 5
- 239000008267 milk Substances 0.000 description 5
- 210000004080 milk Anatomy 0.000 description 5
- 230000001954 sterilising effect Effects 0.000 description 5
- 235000005687 corn oil Nutrition 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 238000004108 freeze drying Methods 0.000 description 4
- 238000011068 loading method Methods 0.000 description 4
- 210000004877 mucosa Anatomy 0.000 description 4
- 206010013786 Dry skin Diseases 0.000 description 3
- 239000002202 Polyethylene glycol Substances 0.000 description 3
- 235000013339 cereals Nutrition 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 238000004821 distillation Methods 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 239000012982 microporous membrane Substances 0.000 description 3
- 235000012424 soybean oil Nutrition 0.000 description 3
- 239000003549 soybean oil Substances 0.000 description 3
- 238000004659 sterilization and disinfection Methods 0.000 description 3
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 2
- JGSARLDLIJGVTE-UHFFFAOYSA-N 3,3-dimethyl-7-oxo-6-[(2-phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid Chemical compound O=C1N2C(C(O)=O)C(C)(C)SC2C1NC(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-UHFFFAOYSA-N 0.000 description 2
- 208000005577 Gastroenteritis Diseases 0.000 description 2
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical class C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 description 2
- LNOHXHDWGCMVCO-UHFFFAOYSA-N Wogonoside Natural products C1=C(O)C(C(C=C(O2)C=3C=CC=CC=3)=O)=C2C(OC)=C1OC1OC(C(O)=O)C(O)C(O)C1O LNOHXHDWGCMVCO-UHFFFAOYSA-N 0.000 description 2
- 230000000845 anti-microbial effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 210000000481 breast Anatomy 0.000 description 2
- 238000000265 homogenisation Methods 0.000 description 2
- 239000000787 lecithin Substances 0.000 description 2
- 229940067606 lecithin Drugs 0.000 description 2
- 235000010445 lecithin Nutrition 0.000 description 2
- 239000002502 liposome Substances 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 230000007096 poisonous effect Effects 0.000 description 2
- 229920001983 poloxamer Polymers 0.000 description 2
- 229960000502 poloxamer Drugs 0.000 description 2
- 229920001993 poloxamer 188 Polymers 0.000 description 2
- 238000010298 pulverizing process Methods 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 238000001694 spray drying Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- LNOHXHDWGCMVCO-NTKSAMNMSA-N wogonin 7-O-beta-D-glucuronide Chemical compound C1=C(O)C(C(C=C(O2)C=3C=CC=CC=3)=O)=C2C(OC)=C1O[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LNOHXHDWGCMVCO-NTKSAMNMSA-N 0.000 description 2
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- 208000004429 Bacillary Dysentery Diseases 0.000 description 1
- FXNFHKRTJBSTCS-UHFFFAOYSA-N Baicalein Natural products C=1C(=O)C=2C(O)=C(O)C(O)=CC=2OC=1C1=CC=CC=C1 FXNFHKRTJBSTCS-UHFFFAOYSA-N 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 description 1
- 206010017915 Gastroenteritis shigella Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 208000037319 Hepatitis infectious Diseases 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 238000012356 Product development Methods 0.000 description 1
- 206010037596 Pyelonephritis Diseases 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 208000012873 acute gastroenteritis Diseases 0.000 description 1
- 206010001093 acute tonsillitis Diseases 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- UDFLTIRFTXWNJO-UHFFFAOYSA-N baicalein Chemical compound O1C2=CC(=O)C(O)=C(O)C2=C(O)C=C1C1=CC=CC=C1 UDFLTIRFTXWNJO-UHFFFAOYSA-N 0.000 description 1
- 229940015301 baicalein Drugs 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 description 1
- 229940093471 ethyl oleate Drugs 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 229940093181 glucose injection Drugs 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 208000005252 hepatitis A Diseases 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 230000002101 lytic effect Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 229940052404 nasal powder Drugs 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 150000004053 quinones Chemical class 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 201000005113 shigellosis Diseases 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000009827 uniform distribution Methods 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
Abstract
Description
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2006100874792A CN101088523B (zh) | 2006-06-12 | 2006-06-12 | 黄芩天然活性成分的固体脂质纳米粒及其制备方法和制剂 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2006100874792A CN101088523B (zh) | 2006-06-12 | 2006-06-12 | 黄芩天然活性成分的固体脂质纳米粒及其制备方法和制剂 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101088523A true CN101088523A (zh) | 2007-12-19 |
CN101088523B CN101088523B (zh) | 2012-08-22 |
Family
ID=38942122
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2006100874792A Active CN101088523B (zh) | 2006-06-12 | 2006-06-12 | 黄芩天然活性成分的固体脂质纳米粒及其制备方法和制剂 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101088523B (zh) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102727793A (zh) * | 2012-06-29 | 2012-10-17 | 海南美兰史克制药有限公司 | 一种益坤宁药物组合物固体脂质纳米粒制剂 |
CN104258402B (zh) * | 2014-09-28 | 2017-01-11 | 青岛橡胶谷知识产权有限公司 | 一种汉黄芩素组合物及其制备方法 |
CN107007503A (zh) * | 2017-04-26 | 2017-08-04 | 烟台新时代健康产业日化有限公司 | 一种抑菌组合物及其制备方法和应用 |
CN107412090A (zh) * | 2017-04-26 | 2017-12-01 | 烟台新时代健康产业日化有限公司 | 一种长效抑菌组合物及其制备方法和应用 |
CN110051654A (zh) * | 2019-04-19 | 2019-07-26 | 天津中医药大学 | N-三甲基壳聚糖修饰的黄芩素眼用脂质纳米粒制剂及其制备方法 |
CN110227062A (zh) * | 2019-07-18 | 2019-09-13 | 泉州师范学院 | 一种黄芩苷脂质体软膏及其制备方法 |
CN115475170A (zh) * | 2022-09-23 | 2022-12-16 | 南华大学 | 一种吴茱萸碱衍生物抗浅部真菌固体脂质纳米粒凝胶的制备方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2628317B1 (fr) * | 1988-03-09 | 1991-11-08 | Lvmh Rech | Composition a base de phases lamellaires lipidiques hydratees ou de liposomes contenant un extrait de scutellaria, ou au moins un flavonoide tel que baicaleine ou baicaline et composition cosmetique ou pharmaceutique, notamment dermatologique, a activite anti-allergique, anti-inflammatoire ou anti-vieillissement, l'incorporant |
CN1562147A (zh) * | 2004-03-24 | 2005-01-12 | 杭州华东医药集团生物工程研究所有限公司 | 黄芩提取物冻干粉针剂及其制备方法 |
-
2006
- 2006-06-12 CN CN2006100874792A patent/CN101088523B/zh active Active
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102727793A (zh) * | 2012-06-29 | 2012-10-17 | 海南美兰史克制药有限公司 | 一种益坤宁药物组合物固体脂质纳米粒制剂 |
CN104258402B (zh) * | 2014-09-28 | 2017-01-11 | 青岛橡胶谷知识产权有限公司 | 一种汉黄芩素组合物及其制备方法 |
CN107007503A (zh) * | 2017-04-26 | 2017-08-04 | 烟台新时代健康产业日化有限公司 | 一种抑菌组合物及其制备方法和应用 |
CN107412090A (zh) * | 2017-04-26 | 2017-12-01 | 烟台新时代健康产业日化有限公司 | 一种长效抑菌组合物及其制备方法和应用 |
CN110051654A (zh) * | 2019-04-19 | 2019-07-26 | 天津中医药大学 | N-三甲基壳聚糖修饰的黄芩素眼用脂质纳米粒制剂及其制备方法 |
CN110227062A (zh) * | 2019-07-18 | 2019-09-13 | 泉州师范学院 | 一种黄芩苷脂质体软膏及其制备方法 |
CN115475170A (zh) * | 2022-09-23 | 2022-12-16 | 南华大学 | 一种吴茱萸碱衍生物抗浅部真菌固体脂质纳米粒凝胶的制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN101088523B (zh) | 2012-08-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101088524B (zh) | 黄芩天然活性成分的磷脂复合物及其制备方法和制剂 | |
CN101088523B (zh) | 黄芩天然活性成分的固体脂质纳米粒及其制备方法和制剂 | |
CN101485629B (zh) | 一种给药***及其制备方法 | |
CN110035774A (zh) | ***素的可稀释制剂及其制备方法 | |
US20020119916A1 (en) | Elemental nanoparticles of substantially water insoluble materials | |
CN103705469B (zh) | 一种和厚朴酚纳米粒及其制备方法 | |
WO2011069414A1 (zh) | 一种中药挥发油注射溶液及其注射剂和制备方法 | |
CN102824356A (zh) | 一种黄芩苷纳晶混悬剂、纳晶干粉及其制备方法 | |
CN100518831C (zh) | 固体纳米药物及其制备方法 | |
CN101612124B (zh) | 一种类脂质体及其制剂的制备方法 | |
CN100536921C (zh) | 过饱和阳离子自乳化给药***及其制备方法 | |
CN110559682A (zh) | 一种植物提取物纳米粒及其制备方法和应用 | |
CN100546579C (zh) | 替莫唑胺聚乳酸纳米微球与制剂及其制备方法 | |
Mosaddik et al. | Development and use of polymeric nanoparticles for the encapsulation and administration of plant extracts | |
CN105726494B (zh) | 穿心莲内酯纳米混悬剂组合物及其制备方法和应用 | |
CN105902525A (zh) | 绿原酸纳米粉雾剂在治疗急性肺损伤的药中的应用 | |
CN101524329A (zh) | 双环醇亚微乳及其制备方法 | |
CN101204392A (zh) | 可自微乳化的黄豆苷元口服制剂组合物及其制备方法 | |
CN102552182A (zh) | 胶核脂质体冻干粉及其制备方法 | |
CN105748437A (zh) | 囊泡、囊泡制剂及其制备方法 | |
CN101147727A (zh) | 莪术醇亚微乳及其制备方法和制剂 | |
CN107019682B (zh) | 一种尼莫地平脂质纳米粒及其制备工艺 | |
CN101904820A (zh) | 槲皮素纳米混悬剂冻干组合物及其制备方法和应用 | |
CN102078301A (zh) | 以白蛋白与磷脂为载体的多西他赛纳米制剂及其制备方法 | |
CN102988484B (zh) | 黄芩天然活性成分的磷脂复合物及其制备方法和制剂 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C57 | Notification of unclear or unknown address | ||
DD01 | Delivery of document by public notice |
Addressee: Qu Jinglai Document name: Notification of Passing Examination on Formalities |
|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: SHENZHEN QIWANG INVESTMENT CO., LTD. Free format text: FORMER OWNER: DABAIHUI BIOTECHNOLOGY (SHENZHEN) CO., LTD. Effective date: 20100322 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 518029 8/F, UNIT 2, HAILAN 1ST TOWER, LANJUN PLAZA, DONGHE ROAD, SHATOUJIAO, YANTIAN DISTRICT, SHENZHEN CITY, GUANGDONG PROVINCE TO: 518000 619A, EAST 6/F, BUILDING 2, SAIGE SCIENCE AND TECHNOLOGY PARK, HONGLI ROAD, FUTIAN DISTRICT, SHENZHEN CITY, GUANGDONG PROVINCE |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20100322 Address after: 518000, second, east 6 floor, SEG Science Park, Hongli Road, Shenzhen, Guangdong, Futian District, 619A Applicant after: Shenzhen Qiwang Investement Co., Ltd. Address before: 518029, Shenzhen, Guangdong province Yantian District, Sha Tau Kok, East and Blue Road County Plaza, sea blue, unit two, eight, F Applicant before: Dabaihui Biotechnology (Shenzhen) Co., Ltd. |
|
ASS | Succession or assignment of patent right |
Owner name: BEIJING WUHE BOAO PHARMACEUTICAL TECHNOLOGY DEVELO Free format text: FORMER OWNER: SHENZHEN QIWANG INVESTMENT CO., LTD. Effective date: 20100901 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 518000 619A, EAST 6/F, BUILDING 2, SAIGE SCIENCE PARK, HONGLI ROAD, FUTIAN DISTRICT, SHENZHEN CITY, GUANGDONG PROVINCE TO: 100080 NO.19, TIANHE WEST ROAD, DAXING BIOPHARMACEUTICAL INDUSTRY BASE, ZHONGGUANCUN SCIENCE PARK, BEIJING |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20100901 Address after: 100080, Zhongguancun Beijing science and Technology Park, Daxing pharmaceutical industry base, Tianhe West Road, No. 19 Applicant after: Beijing Wuhe Boao Medical Technology Development Co., Ltd. Address before: 518000, second, east 6 floor, SEG Science Park, Hongli Road, Shenzhen, Guangdong, Futian District, 619A Applicant before: Shenzhen Qiwang Investement Co., Ltd. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee |
Owner name: BEIJING WUHE BOAO PHARMACEUTICAL CO., LTD. Free format text: FORMER NAME: BEIJING WUHE BOAO MEDICAL TECHNOLOGY DEVELOPMENT CO., LTD. |
|
CP03 | Change of name, title or address |
Address after: 102600 Zhongguancun Daxing District science and Technology Park Daxing biomedical industry base, Fu Fu Street, No. 30 Patentee after: Beijing Wehand-Bio Pharmaceutical Co., Ltd. Address before: 100080, Zhongguancun Beijing science and Technology Park, Daxing pharmaceutical industry base, Tianhe West Road, No. 19 Patentee before: Beijing Wuhe Boao Medical Technology Development Co., Ltd. |
|
CP03 | Change of name, title or address |
Address after: 102600 30 Tianfu street, Daxing biomedical industry base, Zhongguancun Science and Technology Park, Daxing District, Beijing Patentee after: Beijing wuhebao Pharmaceutical Co.,Ltd. Address before: 102600 No.30 Tianfu street, Daxing biomedical industry base, Zhongguancun Science and Technology Park, Daxing District, Beijing Patentee before: BEIJING WEHAND-BIO PHARMACEUTICAL Co.,Ltd. |
|
CP03 | Change of name, title or address |